Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Neighbourly Pharmacy Inc T.NBLY

Neighbourly Pharmacy Inc. is a Canada-based company that operates a network of community pharmacies. The Company is an owner and operator of retail pharmacies located throughout Canada under banners such as IDA/Guardian, Pharmachoice, Pharmasave and Remedy’s RX. The Company, through its subsidiaries, owns and operates a network of retail pharmacies known as Rubicon Pharmacies (Rubicon or Rubicon Pharmacies. The Company owns and operates approximately 287 locations across seven provinces and one territory, a coast-to-coast footprint that provides scale and diversification. The Company’s pharmacies provide accessible healthcare with a personal touch. The Company also owns British Columbia-based pharmacies.


TSX:NBLY - Post by User

Comment by Kanatainvestoron Dec 18, 2023 11:35am
126 Views
Post# 35789894

RE:RE:RE:As Long as the "Formal Valuation" is a minimum $18.50...

RE:RE:RE:As Long as the "Formal Valuation" is a minimum $18.50...
PCP doesn't need the board or TD’s fairness opinion to call a special shareholders meeting and put the deal to a vote. (Any shareholder who owns 5% or more of the share can put pretty much anything to a vote). The way, the stock is trading tells me that the market doesn’t believe that PCP can get the majority of the minority of the vote. As such, PCP will either have to up the offer or abandon the deal.

Incredibly, PCP has put the board in a very difficult position. If the Board accepts the deal they expose themselves to legal liability, and if they reject the deal, they end up in a battling the majority shareholder.

The difference between $18.5 and $20.5 is a mere $44m in added cost to PCP. This is not a large bridge to cross for this deal to proceed without turning into an ugly and hostile battle. I for once will not accept any offer that doesn’t have a $2 at the start of it and will vote no against any such proposal should it ever make it to a vote.
<< Previous
Bullboard Posts
Next >>